JPH047193B2 - - Google Patents

Info

Publication number
JPH047193B2
JPH047193B2 JP59122952A JP12295284A JPH047193B2 JP H047193 B2 JPH047193 B2 JP H047193B2 JP 59122952 A JP59122952 A JP 59122952A JP 12295284 A JP12295284 A JP 12295284A JP H047193 B2 JPH047193 B2 JP H047193B2
Authority
JP
Japan
Prior art keywords
dna
plasmid
add
coli
restriction enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59122952A
Other languages
Japanese (ja)
Other versions
JPS615783A (en
Inventor
Kenji Oita
Keiko Nakamura
Hideo Ookawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP12295284A priority Critical patent/JPS615783A/en
Publication of JPS615783A publication Critical patent/JPS615783A/en
Priority to JP25543090A priority patent/JPH03172175A/en
Publication of JPH047193B2 publication Critical patent/JPH047193B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、ラツト肝チトクロムP−450c遣伝子
を組込んだ組換えプラスミドに関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a recombinant plasmid incorporating the rat liver cytochrome P-450c gene.

3−メチルコラントレン投与により誘導される
ラツト肝チトクロムP−450cは、還元型で一酸化
炭素と結合し、その差スペクトルが447nmに吸
収極大を示すヘム蛋白質であり、ステロイドや脂
肪酸の代謝、外来の脂溶性有機化合物の酸化的代
謝反応あるいは化学変異剤の代謝活性化などに関
与している。本発明は、この高い水酸化活性を有
し、しかも基質特異性の幅が広いチトクロムP−
450cを大腸菌内で発現させ、工業的なレベルでの
酸化反応過程や産業排水中の有機化合物の酸化除
去等に応用することを可能にする大腸菌内発現用
のプラスミドを提供するものである。
Rat liver cytochrome P-450c, which is induced by administration of 3-methylcholanthrene, is a heme protein that binds to carbon monoxide in its reduced form, and its difference spectrum shows an absorption maximum at 447 nm. It is involved in the oxidative metabolic reactions of fat-soluble organic compounds and the metabolic activation of chemical mutagens. The present invention is directed to cytochrome P-, which has high hydroxylation activity and a wide range of substrate specificity.
The present invention provides a plasmid for expressing 450c in Escherichia coli, which makes it possible to apply it to oxidation reaction processes at an industrial level, oxidative removal of organic compounds in industrial wastewater, etc.

近年、高等生物由来の生理活性ペプチドをコー
ドするcDNAあるいは合成DNAにプロモータを
接続することにより構築したプラスミドを大腸菌
に導入し、生理活性ペプチドを大腸菌に発現させ
た例は少なくない。インスリン、成長ホルモン、
インターフエロン等は工業的レベルでの微生物生
産が試みられている。しかしながら、細胞のミク
ロソーム膜に局在し、分子量も59300ダルトンと
大きくしかも蛋白分子内にヘムを含有しているチ
トクロムP−450については、現在のところ大腸
菌内で発現を行つた報告はない。
In recent years, there have been many cases in which a plasmid constructed by connecting a promoter to a cDNA or synthetic DNA encoding a bioactive peptide derived from a higher organism was introduced into E. coli, and the bioactive peptide was expressed in E. coli. insulin, growth hormone,
Attempts have been made to produce interferon and the like using microorganisms at an industrial level. However, as for cytochrome P-450, which is localized in the microsomal membrane of cells, has a large molecular weight of 59,300 Daltons, and contains heme in its protein molecule, there is currently no report on its expression in E. coli.

本発明者らは、ラツト肝チトクロムP−450cの
大腸菌内発現について、種々研究を行ない本発明
を完成した。
The present inventors conducted various studies on the expression of rat liver cytochrome P-450c in Escherichia coli and completed the present invention.

本発明の大腸菌内発現を目的とした組換え体プ
ラスミドpMG1は、強力プロモーターであるtac
プロモーターの下流に、高い酸化活性を示すラツ
ト肝のチトクロムP−450c遺伝子が連結してい
る。さらに、大腸菌での発現を調節する転写因子
であるSD配列やSD配列と開始コドン間の距離等
も十分満たされている。
The recombinant plasmid pMG1 of the present invention intended for expression in E. coli has a strong promoter, tac.
The rat liver cytochrome P-450c gene, which exhibits high oxidative activity, is linked downstream of the promoter. Furthermore, the SD sequence, which is a transcription factor that regulates expression in E. coli, and the distance between the SD sequence and the start codon, etc., are sufficiently satisfied.

取得したpMG1プラスミドを用いて大腸菌を形
質転換することにより、大腸菌細胞内にラツト肝
チトクロムP−450cが合成され、それを分離、精
製することができる。このようにして、得られた
チトクロムP−450c標品とラツト肝のNADPH
−チトクロムP−450c還元酵素をともに同時固定
化し、酸化反応を行わせることが可能である。ま
た、産生チトクロムP−450cを分離、精製せず、
酸化反応を司どる大腸菌として、固定化し、バイ
オリアクターとして応用することもでき、また、
活性汚泥に加えることも可能である。
By transforming E. coli using the obtained pMG1 plasmid, rat liver cytochrome P-450c is synthesized within the E. coli cells, and it can be isolated and purified. In this way, the obtained cytochrome P-450c specimen and rat liver NADPH
- It is possible to simultaneously immobilize cytochrome P-450c reductase and perform an oxidation reaction. In addition, the produced cytochrome P-450c is not separated or purified,
As Escherichia coli controls the oxidation reaction, it can be immobilized and applied as a bioreactor.
It is also possible to add it to activated sludge.

本発明の組換えプラスミドpMG1は、第1a図
から第1e図に示された塩基配列をもつ組換えプ
ラスミドpAU157を大腸菌の強力プロモーターで
あるtacプロモーターに接続することにより構築
できる。
The recombinant plasmid pMG1 of the present invention can be constructed by connecting the recombinant plasmid pAU157 having the base sequences shown in FIGS. 1a to 1e to the tac promoter, which is a strong promoter of E. coli.

tacプロモーターは、trpプロモーターの“−35
領域”とlacUV5プロモーターの“−10領域”か
ら構成されている大腸菌の強力プロモーターの1
つである。
The tac promoter is “−35” of the trp promoter.
One of the strong promoters of E. coli, consisting of the “-10 region” of the lacUV 5 promoter.
It is one.

次に実施例により本発明について詳細に説明す
る。
Next, the present invention will be explained in detail with reference to Examples.

実施例 ラツト肝チトクロムP−450c遺伝子の大腸菌内
発現を目的とした発現用プラスミドpMG1の構
築 ラツト肝チトクロムP−450c蛋白質の全コーデ
イング領域をもつ組換え体プラスミドpAU157
(Nucl.Acids.Res.12、p2929−2938に記載の方法
で製造できる。)より単離したチトクロムP−
450cの構造遺伝子を、大腸菌の強力プロモーター
であるtacプロモーター(P.L.バイオケミカル社)
に接続し、大腸菌内発現用プラスミドpMG1を以
下のように構築した。pAU157プラスミドに含ま
れるcDNAの塩基配列を第1a図から第1e図に
示す。
Example Construction of expression plasmid pMG1 for expression of rat liver cytochrome P-450c gene in E. coli Recombinant plasmid pAU157 containing the entire coding region of rat liver cytochrome P-450c protein
(Can be produced by the method described in Nucl. Acids. Res. 12 , p. 2929-2938).
The structural gene of 450c was transferred to the tac promoter (PL Biochemical Co., Ltd.), a strong E. coli promoter.
A plasmid pMG1 for expression in E. coli was constructed as follows. The base sequence of the cDNA contained in the pAU157 plasmid is shown in Figures 1a to 1e.

発現ベクターpDG1の構築 発現用プラスミドpMG1構築の第一段階とし
て、tacプロモーターを保持する発現ベクター
pDR540(PLバイオケミカル社)を改変し、新
たな発現ベクターpDG1を構築した。第2図に
その概要を示す。以下に、2つのステツプに分
け、その構築の方法を述べる。
Construction of expression vector pDG1 As the first step in constructing the expression plasmid pMG1, we created an expression vector carrying the tac promoter.
A new expression vector pDG1 was constructed by modifying pDR540 (PL Biochemical). Figure 2 shows the outline. Below, we will explain how to construct it in two steps.

ステツプ1:pDR540プラスミドの部分的分解 1μgのpDR540プラスミドDNAに、2ユニツ
トの制限酵素BamHI(宝酒造)を加え、10μ
のBamHI反応液〔10mM Tris−HCl(PH
8.0)、7mM MgCl2、100mM NaCl、2m
M2−メルカプトエタノール、0.01%ウシ血清
アルブミン〕中で37℃1時間反応した。つぎに
この反応液に1ユニツトのS1ヌクレース(PL
バイオケミカル社)および10μのS1ヌクレー
ス反応液〔100mM NaOAc−HOAc(PH4.0)、
300mM NaCl、12mM ZnSO4〕を加え、さ
らに18℃で2時間反応させた。反応後、反応液
に等量のフエノール−クロロホルム溶液〔フエ
ノール:クロロホルム(1:1)〕を加え、混
合し、10000rpmで5分間遠心後、上澄を分取
した。つぎに、2倍量の冷エタノールを加えて
−80℃に15分間放置した後、10000rpmで10分
間遠心し、DNAを回収し、10μの蒸留水に
懸濁した。
Step 1: Partial digestion of pDR540 plasmid Add 2 units of restriction enzyme BamHI (Takara Shuzo) to 1 μg of pDR540 plasmid DNA and digest with 10 μg of pDR540 plasmid DNA.
BamHI reaction solution [10mM Tris-HCl (PH
8.0), 7mM MgCl 2 , 100mM NaCl, 2m
The reaction was carried out in M2-mercaptoethanol and 0.01% bovine serum albumin at 37°C for 1 hour. Next, add one unit of S1 nuclease (PL) to this reaction solution.
Biochemical) and 10μ S1 nuclease reaction solution [100mM NaOAc-HOAc (PH4.0),
300mM NaCl, 12mM ZnSO4 ] was added, and the mixture was further reacted at 18°C for 2 hours. After the reaction, an equal volume of phenol-chloroform solution [phenol:chloroform (1:1)] was added to the reaction solution, mixed, and after centrifugation at 10,000 rpm for 5 minutes, the supernatant was collected. Next, twice the volume of cold ethanol was added and the mixture was left at -80°C for 15 minutes, followed by centrifugation at 10,000 rpm for 10 minutes to collect DNA and suspend it in 10μ of distilled water.

ステツプ2:pDG1の構築 ステツプ1で調製した10μのDNA溶液に
1μgのBglリンカー(宝酒造)および4ユニ
ツトのT4DNAリガーゼ(宝酒造)を加え、
20μのT4DNAリガーゼ反応液〔66mM
Tris−HCl(PH7.6)、6.6mM MgCl2、10mM
dithiothreitol、1.0mM ATP〕中で16℃15
時間反応させた。反応後、反応液をCohenらの
方法(Proc.Natl.Acad.Sci.U.S.A.69、p2110−
2114)を用いて、大腸菌(Escheric hia coli)
DH1株(F-、recA1、endA1、gyrA96、thi−
1、hsdR17、supE44、λ-、九州大学医学部遺
伝情報施設保存菌株・住友化学工業株式会社宝
塚総合研究所にても保存)に形質転換し、
100μg/mlのアンピシリン(シグマ社)を含
むLBプレート(1当り10gのポリペプトン、
5gのイーストエキストラクト、5gのNaCl、
12gの寒天を含む)に形質転換体を広げ、出現
したコロニーを単離した。つぎに、Birnboim
らの方法(Nucl、Acids、Res.、p1513−
1523)に従つて、コロニーよりプラスミド
DNAを調製し、1μgのプラスミドDNAに対
し、1ユニツトの制限酵素Bglを加えて、
Bgl反応液〔10mM Tris−HCl(PH7.5)、7
mM MgCl2、100mM NaCl、7mM2−メ
ルカプトエタノール〕中で、37℃、1時間反応
した。反応後、反応液を0.1μg/mlの臭化エチ
ジウム(アルドリツチ社)を含む1.0%のアガ
ロースゲル(シグマ社)に供し、100Vで60分
間電気泳動した。紫外線ランプ下で泳動パター
ンを観察し、制限酵素Bglで1カ所切断を受
けたプラスミドを選択し、pDG1プラスミドと
名付けた。構築した発現ベクターは、tacプロ
モーターを保持し、SD配列の下流7塩基に、
制限酵素Bglの認識部位を持つており、この
部位に目的のDNA断片を組込むことにより、
目的蛋白質の発現を行うことができる。
Step 2: Construction of pDG1 Add 10μ of DNA solution prepared in Step 1.
Add 1 μg of Bgl linker (Takara Shuzo) and 4 units of T 4 DNA ligase (Takara Shuzo),
20μ T 4 DNA ligase reaction solution [66mM
Tris-HCl (PH7.6), 6.6mM MgCl2 , 10mM
dithiothreitol, 1.0mM ATP] at 16℃15
Allowed time to react. After the reaction, the reaction solution was prepared using the method of Cohen et al. (Proc. Natl. Acad. Sci. USA 69 , p2110-
Escheric hia coli
DH1 strain (F- , recA1, endA1, gyrA96, thi-
1. Transformed into hsdR17, supE44, λ - (also preserved at Kyushu University School of Medicine Genetic Information Facility / Sumitomo Chemical Co., Ltd. Takarazuka Research Institute),
LB plates containing 100 μg/ml ampicillin (Sigma) (10 g polypeptone per plate,
5g yeast extract, 5g NaCl,
The transformants were spread on 12 g of agar (containing 12 g of agar), and the colonies that appeared were isolated. Next, Birnboim
method (Nucl, Acids, Res. 7 , p1513-
1523), plasmids from colonies according to
Prepare DNA, add 1 unit of restriction enzyme Bgl to 1 μg of plasmid DNA,
Bgl reaction solution [10mM Tris-HCl (PH7.5), 7
The reaction was carried out at 37° C. for 1 hour in mM MgCl 2 , 100 mM NaCl, 7 mM 2-mercaptoethanol. After the reaction, the reaction solution was applied to a 1.0% agarose gel (Sigma) containing 0.1 μg/ml ethidium bromide (Aldrich) and electrophoresed at 100 V for 60 minutes. The migration pattern was observed under an ultraviolet lamp, and a plasmid that had been cleaved at one site with the restriction enzyme Bgl was selected and named pDG1 plasmid. The constructed expression vector retains the tac promoter and has 7 bases downstream of the SD sequence,
It has a recognition site for the restriction enzyme Bgl, and by incorporating the desired DNA fragment into this site,
A target protein can be expressed.

tacプロモーターとチトクロムP−450cの開
始コドンを含むDNAの結合(pDGN101の構
築) 発現用プラスミドpMG1構築の第二段階とし
て、で構築した発現ベクターpDG1より、
tacプロモーターを含むEcoR−BglDNA
断片を単離し、これに、チトクロムP−450遺
伝子の開始コドンを含む約300塩基対のSau3A
−Pst断片を接続し、組換え体プラスミド
pDGN101を得た。構築の概要を第3図に示し、
以下、4つのステツプに分け、その構築の方法
を述べる。
Binding of DNA containing the tac promoter and the initiation codon of cytochrome P-450c (construction of pDGN101) As the second step in constructing the expression plasmid pMG1, from the expression vector pDG1 constructed in
EcoR-BglDNA containing tac promoter
A fragment was isolated containing approximately 300 base pairs of Sau3A containing the start codon of the cytochrome P-450 gene.
- Connect the Pst fragments and create a recombinant plasmid.
pDGN101 was obtained. The outline of the construction is shown in Figure 3.
Below, we will explain how to construct it, dividing it into four steps.

ステツプ1:3600塩基対のEcoR−Pst断片
の調製 1μgのpBR322DNA(和光純薬)に、1ユ
ニツトの制限酵素EcoR(宝酒造)および
1ユニツトの制限酵素Pst(宝酒造)を加
え、20μのEcoR反応液〔100mM Tris
−HCl、(PH7.5)、7mM MgCl2、50mM
NaCl、7mM2−メルカプトエタノール、
0.01%ウシ血清アルブミン〕中で37℃1時間
反応した。反応後、反応液を0.1μg/mlの臭
化エチジウムを含む1.0%の低融点アガロー
スゲル(ベセスダ・リサーチ社)に供し、電
気泳動を行つた。泳動後、紫外線ランプ下
で、3.6KbのEcoR−Pst DNA断片に
相当するゲル部分を切り出し、エツペンドル
フ管にとり、65℃で5分間加熱した。融解し
たゲルに2倍量のTE緩衝液〔10mM Tris
−HCl(PH8.0)、0.5mM EDTA〕を加え、
次にTE緩衝液で飽和したフエノールを加え
て、フエノール抽出を行つた。10000r.p.m.
で5分間遠心し、上層を分取した後、140量
の4MNaClおよび2倍量のエタノールを加え
て−80℃に10分間放置することによりDNA
をエタノール沈殿した。その後10000rpmで
10分間遠心し、約0.2μgの3.6Kb EcoR−
Pst DNA断片を回収し、10μの蒸留水
に懸濁した。
Step 1: Preparation of 3600 base pair EcoR-Pst fragment Add 1 unit of restriction enzyme EcoR (Takara Shuzo) and 1 unit of restriction enzyme Pst (Takara Shuzo) to 1 μg of pBR322 DNA (Wako Pure Chemical Industries), and add 20 μg of EcoR reaction solution. [100mM Tris
-HCl, (PH7.5), 7mM MgCl2 , 50mM
NaCl, 7mM 2-mercaptoethanol,
0.01% bovine serum albumin] at 37°C for 1 hour. After the reaction, the reaction solution was applied to a 1.0% low melting point agarose gel (Bethesda Research) containing 0.1 μg/ml ethidium bromide for electrophoresis. After electrophoresis, the gel portion corresponding to the 3.6 Kb EcoR-Pst DNA fragment was cut out under an ultraviolet lamp, placed in an Eppendorf tube, and heated at 65° C. for 5 minutes. Add twice the volume of TE buffer [10mM Tris] to the melted gel.
- Add HCl (PH8.0), 0.5mM EDTA],
Next, phenol saturated with TE buffer was added to perform phenol extraction. 10000r.pm
After centrifuging for 5 minutes at
was precipitated with ethanol. then at 10000rpm
Centrifuge for 10 minutes and collect approximately 0.2μg of 3.6Kb EcoR-
Pst DNA fragments were collected and suspended in 10μ of distilled water.

ステツプ2 tacプロモーター断片の調製 1μgの発現ベクターpDG1に、1ユニツト
の制限酵素EcoRおよび1ユニツトの制限
酵素Bglを加え、20μのEcoR反応液中
で37℃1時間反応した。反応後、ステツプ1
と同様の操作により、低融点アガロース電気
泳動を行い、約420塩基のEcoR−Bgl
DNA断片をゲルより切り出し、DNAを回収
し、10μの蒸留水に懸濁した。
Step 2 Preparation of tac promoter fragment 1 unit of restriction enzyme EcoR and 1 unit of restriction enzyme Bgl were added to 1 μg of expression vector pDG1, and the mixture was reacted in a 20 μg EcoR reaction solution at 37° C. for 1 hour. After reaction, step 1
Perform low melting point agarose electrophoresis using the same procedure as above to perform EcoR-Bgl of approximately 420 bases.
DNA fragments were excised from the gel, the DNA was collected, and suspended in 10μ of distilled water.

ステツプ3 チトクロムP−450c遺伝子の開始
コドンを含むSau3A1−Pst断片の調製 5μgのpAU157DNAに、5ユニツトの制
限酵素Pstを加え、20μのPst反応液
〔20mM Tris−HCl(PH7.5)、10mM
MgCl2、50mM(NH42SO4、0.01%ウシ血清
アルブミン〕中で37℃1時間反応し、低融点
アガロース電気泳動後、約300塩基対のPst
DNA断片を切り出し、DNA回収後、10μ
の蒸留水に懸濁した。なお、このDNA断片
中にあるSau3A1切断部位の4塩基下流にチ
トクロムP−450c遺伝子の開始コドンが存在
していることが判明している。そこで、この
PstDNA断片を含む溶液に、3ユニツトの
制限酵素Sau3A1(宝酒造)を加え、20μの
Sau3A1反応液〔10mM Tris−HCl(PH
7.5)、7mM MgCl2、100mM NaCl〕中
で37℃1時間反応させ、等量のフエノール−
クロロホルム溶液で処理後、DNAを回収し、
10μの蒸留水に懸濁した。第3図から明ら
かなように、このDNA溶液には、2種類の
DNA断片が混在している。
Step 3 Preparation of Sau3A1-Pst fragment containing the start codon of cytochrome P-450c gene Add 5 units of restriction enzyme Pst to 5 μg of pAU157 DNA, add 20 μg of Pst reaction solution [20 mM Tris-HCl (PH7.5), 10 mM
MgCl 2 , 50mM (NH 4 ) 2 SO 4 , 0.01% bovine serum albumin] at 37°C for 1 hour, and after electrophoresis on low melting point agarose, approximately 300 base pair Pst
After cutting out the DNA fragment and collecting the DNA, 10μ
was suspended in distilled water. It has been found that the initiation codon of the cytochrome P-450c gene is present 4 bases downstream of the Sau3A1 cleavage site in this DNA fragment. So, this
Add 3 units of restriction enzyme Sau3A1 (Takara Shuzo) to the solution containing the PstDNA fragment, and
Sau3A1 reaction solution [10mM Tris-HCl (PH
7.5), 7mM MgCl 2 , 100mM NaCl] at 37°C for 1 hour, and an equal amount of phenol
After treatment with chloroform solution, DNA was collected and
Suspended in 10μ of distilled water. As is clear from Figure 3, this DNA solution contains two types of
DNA fragments are mixed.

ステツプ4 組換え体プラスミドpDGN101の
構築 ステツプ1・2・3で調製した、3600塩基
対のEcoR−PstDNA断片、400塩基対の
EcoR−BglDNA断片および開始コドン
を保持するSau3A1−PstDNA断片混液を
それぞれ0.2μgづつ混合し、7.2ユニツトの
T4DNAリガーゼを加え、45μのT4DNAリ
ガーゼ反応液中で16℃2時間反応した。その
後、Cohenらの方法に従い、反応液で大腸菌
DH1株を形質転換した。形質転換体を
Rutherらの方法(Mol.Gen.Genetics 178、
P475−477)に従い、200μg/mlの5−ブロ
ム−4−クロル−3−インドリル−β−D−
ガラクトシド(半井化学)、および15μg/
mlのテトラサイクリン(シグマ社)を含む
LBプレートに広げ、出現した青色コロニー
を単離した。前述のBirnboimらの方法に従
い、コロニーよりプラスミドDNAを調製し、
2μgのプラスミドDNAに対し、2ユニツト
の制限酵素Hind(宝酒造)および2ユニ
ツトの制限酵素Bgl(ニツポンジーン)を
加え、20μのHind反応液中で37℃1時間
反応した。反応液を1.0%アガロースゲル電
気泳動で分析し、2300塩基対、900塩基対、
450塩基対、350塩基対および250塩基対の5
つのDNA断片が検出されるプラスミドを選
択し、pDGN101とした。
Step 4 Construction of recombinant plasmid pDGN101 The 3600 base pair EcoR-PstDNA fragment prepared in Steps 1, 2, and 3, and the 400 base pair
Mix 0.2 μg each of the EcoR-Bgl DNA fragment and the Sau3A1-Pst DNA fragment mixture containing the start codon, and make 7.2 units.
T 4 DNA ligase was added, and the mixture was reacted for 2 hours at 16°C in a 45μ T 4 DNA ligase reaction solution. Then, according to the method of Cohen et al., E. coli was grown in the reaction solution.
The DH1 strain was transformed. Transformants
Ruther et al.'s method (Mol.Gen.Genetics 178,
200 μg/ml of 5-bromo-4-chloro-3-indolyl-β-D-
Galactoside (Hani Chemical), and 15μg/
Contains ml of tetracycline (Sigma)
It was spread on an LB plate, and the blue colonies that appeared were isolated. Plasmid DNA was prepared from the colony according to the method of Birnboim et al.
2 units of restriction enzyme Hind (Takara Shuzo) and 2 units of restriction enzyme Bgl (Nippon Gene) were added to 2 μg of plasmid DNA, and the mixture was reacted in a 20 μg Hind reaction solution at 37° C. for 1 hour. The reaction solution was analyzed by 1.0% agarose gel electrophoresis, and 2300 base pairs, 900 base pairs,
5 of 450 base pairs, 350 base pairs and 250 base pairs
A plasmid in which two DNA fragments were detected was selected and named pDGN101.

発現用プラスミドpMG1の構築 で構築した組換え体プラスミドpDGN101
およびpAU157プラスミドとpBR322プラスミ
ドから、発現用プラスミドpMG1を構築した。
構築の概要は第4図に示されている。以下、4
つのステツプに分け、構築の方法について述べ
る。
Construction of expression plasmid pMG1 Recombinant plasmid pDGN101 constructed by
An expression plasmid pMG1 was constructed from the pAU157 plasmid and pBR322 plasmid.
An outline of the construction is shown in Figure 4. Below, 4
We will explain the construction method in two steps.

ステツプ1 300塩基のHind−Pst断片の
調製 2μgのpDGN101プラスミドに、2ユニツ
トの制限酵素Hindを加え、20μのHind
反応液中で37℃1時間反応し、1.0%低融
点アガロース電気泳動を行い、3900塩基対の
HindDNA断片を単離した。つぎにこの
DNA溶液に、2ユニツトの制限酵素Pstを
加え、20μのPst反応液中で37℃1時間
反応し、同様の操作により、tacプロモータ
ーを含む300塩基対のHind−PstDNA断
片を調製した。このDNAを、以後、DNA断
片aと呼ぶ。
Step 1 Preparation of 300 base Hind-Pst fragment Add 2 units of restriction enzyme Hind to 2 μg of pDGN101 plasmid, and add 20 μg of Hind-Pst fragment.
After reacting in the reaction solution for 1 hour at 37°C, electrophoresis was performed on 1.0% low melting point agarose, and a 3900 base pair
HindDNA fragment was isolated. Next this
Two units of the restriction enzyme Pst were added to the DNA solution, and the mixture was reacted for 1 hour at 37°C in a 20μ Pst reaction solution, and a 300 base pair Hind-Pst DNA fragment containing the tac promoter was prepared by the same procedure. This DNA is hereinafter referred to as DNA fragment a.

ステツプ2 Pvu−HincDNA断片および
Pst−HincDNA断片の調製 5μgのpAU157プラスミドDNAに5ユニ
ツトの制限酵素Pvu(バイオラボ社)を加
え、20μのPvu反応後〔7mM Tris−
HCl(PH7.4)、150mM NaCl、6mM
MgCl2、6mM2−メルカプトエタノール、
100μg/mlウシ血清アルブミン〕中で37℃
1時間反応し、DNAを回収した。引きつづ
き、このDNA溶液に5ユニツトの制限酵素
Hinc(宝酒造)を加え、20μのHinc
反応液〔10mM Tris−HCl、(PH8.0)、7
mM MgCl2、60mM NaCl、7mM2−メ
ルカプトエタノール〕中で37℃1時間反応
し、1.0%の低融点アガロースゲルで電気泳
動後、3200塩基対のPvu−HincDNA断
片を単離した(DNA断片bとする。) また、同時に2100塩基対のHincDNA断
片を同様の方法で調製し、引きつづきこの
DNA溶液に3ユニツトの制限酵素Pstを加
え、20μのPst反応液中で37℃1時間反
応した。得られた反応生成物を1.0%の低融
点アガロースゲルで分離し、1000塩基対の
Pst−HincDNA断片を単離した(DNA
断片cとする。) ステツプ3 700塩基対のHind−Pvu
DNA断片の調製 2μgのpBR322DNAに2ユニツトの制限
酵素Pvuを加え、20μのPvu反応液中
で37℃1時間反応し、DNAを回収した。次
いでこのDNA溶液に2ユニツトの制限酵素
Hindを加え、20μのHind反応液中で
37℃1時間反応した。反応生成物を、1.0%
低融点アガロースゲルで分離し、700塩基対
のPvu−HindDNA断片を単離した
(DNA断片dとする。) ステツプ4 ステツプ1・2・3で調製したDNAを
各々約0.2μgづつ混合し、3ユニツトの
T4DNAリガーゼを加え、30μのT4DNAリ
ガーゼ反応液中で16℃15時間反応した。反応
後、反応液で大腸菌DH1株を形質転換し、
200μg/mlの5−ブロム−4−クロル−3
−インドリル−β−D−ガラクトシドおよび
10μg/mlのアンピシリン(シグマ社)を含
むLBプレートに広げ、出現した青色コロニ
ーを単離した。コロニーよりプラスミド
DNAを調製し、1μgのプラスミドDNAに対
して1ユニツトの制限酵素Hincを加えて、
20μのHind反応液中で37℃1時間反応さ
せた後、反応生成物を1.0%のアガロ−スゲ
ルで分析したプラスミドのうち、3300塩基
対、500塩基対および1300塩基対のDNA断片
が検出されたプラスミドを選択し、pMG1と
名付けた。
Step 2 Pvu-HincDNA fragment and
Preparation of Pst-HincDNA fragment 5 units of restriction enzyme Pvu (Bio-Labo) was added to 5 μg of pAU157 plasmid DNA, and after 20 μg of Pvu reaction [7mM Tris-
HCl (PH7.4), 150mM NaCl, 6mM
MgCl2 , 6mM2-mercaptoethanol,
100μg/ml bovine serum albumin] at 37℃
After reacting for 1 hour, DNA was collected. Next, add 5 units of restriction enzyme to this DNA solution.
Add Hinc (Takara Shuzo) and 20μ Hinc
Reaction solution [10mM Tris-HCl, (PH8.0), 7
After reaction for 1 hour at 37°C in 1.0% low melting point agarose gel, a 3200 base pair Pvu-Hinc DNA fragment was isolated (DNA fragment b and ) At the same time, a 2100 base pair HincDNA fragment was prepared in the same manner, and this
Three units of restriction enzyme Pst were added to the DNA solution, and the mixture was reacted for 1 hour at 37°C in a 20μ Pst reaction solution. The resulting reaction products were separated on a 1.0% low melting point agarose gel, and the 1000 base pair
Pst-HincDNA fragment was isolated (DNA
Let it be fragment c. ) Step 3 Hind-Pvu of 700 base pairs
Preparation of DNA Fragment Two units of restriction enzyme Pvu were added to 2 μg of pBR322 DNA, and the mixture was reacted in a 20 μg Pvu reaction solution at 37° C. for 1 hour to recover DNA. Next, add 2 units of restriction enzyme to this DNA solution.
Add Hind and dilute in 20μ Hind reaction solution.
The reaction was carried out at 37°C for 1 hour. Reaction product, 1.0%
Separation was performed using a low melting point agarose gel, and a 700 base pair Pvu-Hind DNA fragment was isolated (referred to as DNA fragment d). Step 4: Mix approximately 0.2 μg of each of the DNAs prepared in Steps 1, 2, and 3. unit's
T 4 DNA ligase was added, and the mixture was reacted at 16° C. for 15 hours in a 30μ T 4 DNA ligase reaction solution. After the reaction, transform E. coli strain DH1 with the reaction solution,
200μg/ml 5-bromo-4-chloro-3
-indolyl-β-D-galactoside and
It was spread on an LB plate containing 10 μg/ml ampicillin (Sigma), and the blue colonies that appeared were isolated. Plasmid from colony
Prepare DNA, add 1 unit of restriction enzyme Hinc to 1 μg of plasmid DNA,
DNA fragments of 3300 base pairs, 500 base pairs, and 1300 base pairs were detected among the plasmids, which were analyzed on a 1.0% agarose gel after reacting for 1 hour at 37°C in a 20μ Hind reaction solution. A plasmid was selected and named pMG1.

発現用プラスミドpMG1によるラツト肝チト
クロムP−450cの発現 構築した発現用プラスミドpMG1を用い
て、大腸菌内でラツト肝チトクロムP−450c
の発現を行つた。以下にその詳細な方法を述
べる。
Expression of rat liver cytochrome P-450c using expression plasmid pMG1 Rat liver cytochrome P-450c was expressed in Escherichia coli using the constructed expression plasmid pMG1.
The expression was carried out. The detailed method will be described below.

ステツプ1 マキシ・セル法による発現蛋白の
標識 構築したpMG1プラスミドを、Cohenらの
方法に従い、大腸菌CSR603株(uvrA6、rec
A1、phr、thr、1eu、pro、his、arg、lac、
gal、ara、xy1、mt1、stf)(九州大学理学
部分子遺伝学講座保存菌株;住友化学工業株
式会社、宝塚総合研究所にても保存)に形質
転換し、形質転換体CSR603(pMG1)株を得
た。得られたコロニーを培養し、サンカー
(Sancar)らのマキシセル法(J.M.B 148
p45−62)に従い、発現蛋白の標識を行
た。まず、大腸菌CSR603(pMG1)株を、K
培地〔1%カザミノ酸、0.1μg/mlチアミン
+M9培地、但しM9培地は、Na2HPO4
g、KH2PO4 3g、NaCl 0.5g、NH4Cl
1gに蒸留水を加えて1とし、オートクレ
ーブ後、0.01M CaCl2を10ml、1M MgSO4
を1mlを加えたもの。〕中で37℃1晩培養し
た。その0.1mlを10mlのK培地に植え継ぎ、
37℃でインキユベートして、OD660が0.2にな
るまで増殖させた。滅菌した時計皿に10mlの
培養液を移し、15Wの紫外線ランプ直下約90
cmの距離で、5〜20秒照射した。照射後、培
養液を100ml容三角フラスコに移し、37℃で
1時間培養し、サイクロセリンを100μg/
mlになるように加え、37℃で8〜12時間イン
キユベートした。3000rpmで15分間遠心して
集菌し、ハーシーソルト(5.4g NaCl、3.0
g KCl、1.1g NH4Cl、15mg CaCl2
2H2O、0.2g MgCl2・6H2O、0.2mg
FeCl3・6H2O、87mg KH2PO4、12.1g
Trizmab ase/1)で2回洗浄した。つ
ぎに菌を5mlのハーシ培地〔ハーシソルト
100ml当たり、0.5mlスレオニン(2%)、1
mlロイシン(1%)、1mlプロリン(2%)、
1mlアルギニン(2%)、0.1mlチアミン
(0.1%)〕に懸濁し、37℃1時間インキユベ
ートした。さらに 35S−メチオニン
(1000Ci/mmole)を50μCi/mlになる様に
加え、37℃で1時間インキユベートした。遠
心して集菌し、0.1mlの2%SDS(ドデシル硫
酸ナトリウム)に懸濁後、100℃で4分間熱
処理し、タンパク質を溶解させた。以上のよ
うにして、調製した粗抽出液の25μに対し
て、75μの沈降用緩衝液〔25%TritonX−
100、190mM NaCl、6m MEDTA、50m
M Tris HCl(PH7.4)〕を加え、抗P−
450cIgGを10μgを添加し、4℃で1晩放置
した。これに、T緩衝液〔2%TritonX−
100、2mM Met、150mM NaCl、5m
MEDTA、50mM Tris−HCl(PH7.4)〕で
平衡化したProteinA−SepharoseCL−4B
(フアルマシア社)を50μ添加し、10分ご
とに攪拌しながら、室温で1時間反応させ
た。12000r.p.m.で5分間遠心し、沈殿した
ゲルを1mlのT緩衝液で2回洗浄し非特異的
吸着物を除去した。得られたゲルを50μの
サンプル緩衝液(上記)中で1分間煮沸し
て、ゲルに吸着した免疫沈降物を溶出した
後、溶出液を、Laemmliらの方法(Nature
227 p680−685)に従つて、SDS−ポリアク
リルアミドゲル電気泳動にかけ、フルオログ
ラフイーを行つた。結果を第5図に示す。A
は対称として用いたpAU157の例で、免疫沈
降物は検出されなかつたが、pMG1を用いた
Bではラツト肝チトクロムP−450cに相当す
る免疫沈降物が確認された。また、その発現
量は、検出量から推定して大腸菌細胞当り、
102〜103分子であると考えられる。
Step 1 Labeling of expressed protein by maxi-cell method The constructed pMG1 plasmid was labeled with E. coli strain CSR603 (uvrA6, rec
A1, phr, thr, 1eu, pro, his, arg, lac,
gal, ara, xy1, mt1, stf) (strain kept at Kyushu University Department of Molecular Genetics; also kept at Sumitomo Chemical Co., Ltd. and Takarazuka Research Institute), and the transformant CSR603 (pMG1) strain was transformed into Obtained. The resulting colonies were cultured using the MaxiCell method of Sancar et al. (JMB 148) .
The expressed protein was labeled according to p45-62). First, E. coli CSR603 (pMG1) strain was
Medium [1% casamino acid, 0.1 μg/ml thiamine + M9 medium, however, M9 medium contains Na 2 HPO 4 6
g, KH 2 PO 4 3 g, NaCl 0.5 g, NH 4 Cl
Add distilled water to 1g to make 1, and after autoclaving, add 10ml of 0.01M CaCl 2 and 1M MgSO 4
Add 1 ml of ] and cultured overnight at 37°C. Subplant 0.1ml of that into 10ml of K medium.
Incubate at 37°C and grow to an OD 660 of 0.2. Transfer 10ml of the culture solution to a sterilized watch glass and place it under a 15W ultraviolet lamp for about 90 minutes.
Irradiation was performed for 5 to 20 seconds at a distance of cm. After irradiation, the culture solution was transferred to a 100 ml Erlenmeyer flask, incubated at 37°C for 1 hour, and cycloserine was added at 100 μg/
ml and incubated at 37°C for 8 to 12 hours. Centrifuge at 3000 rpm for 15 minutes to collect bacteria, and add Hershey salt (5.4 g NaCl, 3.0
g KCl, 1.1g NH 4 Cl, 15mg CaCl 2 .
2H 2 O, 0.2g MgCl 2・6H 2 O, 0.2mg
FeCl36H2O , 87mg KH2PO4 , 12.1g
Washed twice with Trizmabase/1). Next, add the bacteria to 5 ml of Hershey medium [Hershey salt
Per 100ml, 0.5ml threonine (2%), 1
ml leucine (1%), 1ml proline (2%),
The suspension was suspended in 1 ml arginine (2%) and 0.1 ml thiamine (0.1%) and incubated at 37°C for 1 hour. Furthermore, 35 S-methionine (1000 Ci/mmole) was added to the solution at a concentration of 50 μCi/ml, and the mixture was incubated at 37° C. for 1 hour. Bacteria were collected by centrifugation, suspended in 0.1 ml of 2% SDS (sodium dodecyl sulfate), and then heat-treated at 100°C for 4 minutes to dissolve the protein. As described above, 75μ of sedimentation buffer [25% TritonX-
100, 190mM NaCl, 6m MEDTA, 50m
M Tris HCl (PH7.4)] and anti-P-
10 μg of 450cIgG was added and left at 4° C. overnight. To this, add T buffer [2% TritonX-
100, 2mM Met, 150mM NaCl, 5m
Protein A-SepharoseCL-4B equilibrated with MEDTA, 50mM Tris-HCl (PH7.4)]
(Pharmacia) was added thereto, and the mixture was allowed to react at room temperature for 1 hour while stirring every 10 minutes. The gel was centrifuged at 12,000 rpm for 5 minutes, and the precipitated gel was washed twice with 1 ml of T buffer to remove non-specifically adsorbed substances. The resulting gel was boiled for 1 minute in 50μ sample buffer (described above) to elute the immunoprecipitate adsorbed to the gel, and the eluate was then purified using the method of Laemmli et al.
227 p680-685), SDS-polyacrylamide gel electrophoresis and fluorography were performed. The results are shown in Figure 5. A
In case of pAU157 used as control, no immunoprecipitate was detected, but in case of B using pMG1, an immunoprecipitate corresponding to rat liver cytochrome P-450c was confirmed. In addition, the expression level is estimated from the detected amount per E. coli cell,
It is thought that there are 10 2 to 10 3 molecules.

以上のことから、大腸菌CSR603株に組換え体
プラスミドpMG1を導入することにより、ラツト
肝チトクロムP−450c蛋白が発現することが確認
された。
From the above, it was confirmed that rat liver cytochrome P-450c protein was expressed by introducing the recombinant plasmid pMG1 into E. coli strain CSR603.

【図面の簡単な説明】[Brief explanation of drawings]

第1a図から第1e図は、pAU157プラスミド
に含まれるcDNAの塩基配列を示す。第2図は、
発現ベクターpDG1構築の概要を示す。第3図
は、プラスミドpDGN101構築の概要を示す。第
4図は、発現用プラスミドpMG1構築の概要を示
す。第5図には、ラツト肝チトクロムP−450c蛋
白の大腸菌内での発現量を示すフルオログラフイ
ー結果を示す。第6図は、発現用プラスミド
pMG1の制限酵素地図を示す。〓はプロモータ
ー、〓は、P−450c遺伝子、〓は、Ori遺伝子、
〓は、アンピシリン耐性遺伝子を表す。また、
AhはAha部位を、EcはEcoR部位を、Hcは
Hinc部位を、HdはHind部位を、PsはPst部
位を、PvはPvu部位を、PvはPvu部位
を表す。
Figures 1a to 1e show the base sequence of cDNA contained in the pAU157 plasmid. Figure 2 shows
An overview of expression vector pDG1 construction is shown. FIG. 3 shows an overview of plasmid pDGN101 construction. FIG. 4 shows an outline of the construction of the expression plasmid pMG1. FIG. 5 shows fluorography results showing the expression level of rat liver cytochrome P-450c protein in E. coli. Figure 6 shows the expression plasmid
A restriction enzyme map of pMG1 is shown. 〓 is promoter, 〓 is P-450c gene, 〓 is Ori gene,
〓 represents ampicillin resistance gene. Also,
Ah is the Aha site, Ec is the EcoR site, and Hc is the
Hinc site, Hd represents Hind site, Ps represents Pst site, Pv represents Pvu site, and Pv represents Pvu site.

Claims (1)

【特許請求の範囲】 1 約5200塩基対からなり、下に示す制限酵素地
図で特徴づけられ、 プロモーターのSD配列とP−450c遺伝子開始
コドンATGの接続部分の塩基配列が、 AGGAAACAGCAGATCATG であるプラスミドpMG1。 2 約5200塩基対からなり、下に示す制限酵素地
図で特徴づけられ、 プロモーターのSD配列とP−450c遣伝子開始
コドンATGの接続部分の塩基配列が、 AGGAAACAGCAGATCATG であるプラスミドpMG1で形質転換した大腸菌。
[Claims] 1 Plasmid pMG1 consisting of approximately 5200 base pairs, characterized by the restriction enzyme map shown below, and having the base sequence AGGAAACAGCAGATCATG at the junction between the SD sequence of the promoter and the P-450c gene start codon ATG. . 2. Transformed with plasmid pMG1, which consists of approximately 5,200 base pairs and is characterized by the restriction enzyme map shown below, and whose base sequence at the junction between the SD sequence of the promoter and the P-450c gene start codon ATG is AGGAAACAGCAGATCATG. E. coli.
JP12295284A 1984-06-16 1984-06-16 Expression plasmid aiming at expression of rat hepatic cytochrome p-450mc gene in escherichia coli Granted JPS615783A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP12295284A JPS615783A (en) 1984-06-16 1984-06-16 Expression plasmid aiming at expression of rat hepatic cytochrome p-450mc gene in escherichia coli
JP25543090A JPH03172175A (en) 1984-06-16 1990-09-27 Production of rat liver cytochrome p-450c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12295284A JPS615783A (en) 1984-06-16 1984-06-16 Expression plasmid aiming at expression of rat hepatic cytochrome p-450mc gene in escherichia coli

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP25543090A Division JPH03172175A (en) 1984-06-16 1990-09-27 Production of rat liver cytochrome p-450c

Publications (2)

Publication Number Publication Date
JPS615783A JPS615783A (en) 1986-01-11
JPH047193B2 true JPH047193B2 (en) 1992-02-10

Family

ID=14848680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12295284A Granted JPS615783A (en) 1984-06-16 1984-06-16 Expression plasmid aiming at expression of rat hepatic cytochrome p-450mc gene in escherichia coli

Country Status (1)

Country Link
JP (1) JPS615783A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240831A (en) * 1991-01-10 1993-08-31 Board Of Regents, The University Of Texas Methods and compositions for the expression of biologically active eukaryotic cytochrome p45os in bacteria
US9255256B2 (en) 1996-07-17 2016-02-09 Btg International Limited Expression of functional cytochorome P450 monooxygenase system in enterobacteria
KR102064080B1 (en) 2018-07-19 2020-01-08 임재천 Automatic Cutting Machine for Elliptical Tubular Shape

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J.BIOCHEM=1983 *
NUCLEIC ACIDS RESEARCH=1984 *

Also Published As

Publication number Publication date
JPS615783A (en) 1986-01-11

Similar Documents

Publication Publication Date Title
Zieg et al. Analysis of the nucleotide sequence of an invertible controlling element.
KR890003083B1 (en) Plasmids containing tetracycline resistance genes, DNA fragments derived therefrom, and microorganisms containing the DNA fragments and methods for producing the same
CN103906833B (en) Protein expression
JPH0665305B2 (en) Method for stabilizing host cell containing recombinant DNA
CZ284017B6 (en) DNAe(L) FRAGMENT ENCODING POLYPEPTIDE WITH NITRILE-HYDRATASE ACTIVITY, TRANSFORMANT CONTAINING SUCH GENE AND PROCESS FOR PREPARING NITRILE-HYDRATASE AND AMIDES BY MAKING USE OF THIS TRANSFORMANT
JPH0759193B2 (en) Cloning vector for foreign protein expression
CN110592058A (en) Threonine aldolase, coding gene thereof and application of threonine aldolase in droxidopa biosynthesis
CN107858340B (en) D-fructose-6-phosphate aldolase A mutant with high catalytic activity, recombinant expression vector, genetically engineered bacteria and its application
Julliot et al. Use of RP4-prime plasmids constructed in vitro to promote a polarized transfer of the chromosome in Escherichia coli and Rhizobium meliloti
JPH047193B2 (en)
CN106701723A (en) D-fructose-6-phosphate aldolase A mutant, recombinant expression vector, genetically engineered bacterium and application and reaction product thereof
CN115873813A (en) Method for synthesizing boldenone through enzyme catalysis cascade
EP0109560A2 (en) Yeast plasmid vector capable of induced expressing and method of using said plasmid
JPH06319564A (en) Production of vitamin C precursors using genetically modified organisms
Hennam et al. Expression of eukaryotic coding sequences in Methylophilus methylotrophus
JP2549504B2 (en) DNA base sequence, polypeptide secretory expression vector and transformed microorganism
JPH0523743B2 (en)
JPH0429352B2 (en)
JPS62262994A (en) D-amino acid oxidase gene
JPH0822223B2 (en) Method for producing PvuI restriction endonuclease
KR102075740B1 (en) A Novel Soluble Methane Monooxygenase Identified By High-Throughput Enzyme Screening System
JP3169927B2 (en) Isolation of polyhydroxyalkanoic acids (PHAs) -deficient strains of Rhodobacter sphaeroides RV with improved hydrogen photoproduction yield
JP2593481B2 (en) DNA having genetic information of sarcosine oxidase and use thereof
JP2538200B2 (en) Polypeptide secretion expression vector and transformed microorganism
JP3012908B2 (en) Dihydrofolate reductase-antiallergic pentapeptide multimer fusion protein (▲I▼)

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term